You Position: Home > Paper

High-dose amoxicillin/esomeprazole dual therapy as a first-line therapy for Helicobacter pylori eradication

( views:169, downloads:0 )
Author:
No author available
Journal Title:
World Chinese Journal of Digestology
Issue:
6
DOI:
10.11569/wcjd.v26.i6.353
Key Word:
幽门螺杆菌;治疗;阿莫西林;临床研究;二联方案

Abstract: 目的 评估大剂量阿莫西林/埃索美拉唑二联方案在幽门螺杆菌(Helicobacter pylori,H.pylori)感染初次治疗患者中的疗效及安全性.方法 142例H.pylori感染的初次治疗患者随机进入大剂量阿莫西林/埃索美拉唑二联方案(EA)组(埃索美拉唑20 mg qid+阿莫西林0.75 g qid,疗程14 d)和铋剂四联方案(EBAC)组(埃索美拉唑20 mg bid十枸橼酸铋钾220 mg bid+阿莫西林1.0 gbid+克拉霉素0.5 gbid,疗程14 d),治疗结束后6 wk复查尿素呼气试验,判断H.pylori根除疗效.结果 共131例患者完成研究,EA组按意向治疗(intention-to-treat,ITT)与按方案(per-protocol,PP)分析H.pylori根除率分别为82.9%和89.2%,EBAC组分别为86.1%和93.9%,两组根除率的ITT、PP分析差异均无统计学意义(P>0.05).按PP分析,EBAC组不良反应发生率明显高于EA组(15.2% vs 3.1%,P<0.05).结论 大剂量阿莫西林/埃索美拉唑二联方案可作为安全、有效的H.pylori感染初次治疗方案.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn